USNAのチャート
USNAの企業情報
| symbol | USNA |
|---|---|
| 会社名 | USANA Health Sciences Inc （USANA HEALTH SCI） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | トイレタリ―用品 一般消費財（Consumer Products） |
| 概要 | USANA・ヘルス・サイエンシズ（USANA Health Sciences Inc.）は科学に基づく栄養・個人介護製品を開発・製造する会社である。同社は南北アメリカと欧州、アジア太平洋の3つの地域（東南アジア太平洋地域、中華、北アジア）の2つの地域で直接販売会社として事業を行っている。その製品ラインにはUSANA Nutritionals Essentials、Optimizers、Foods、Sense-beautiful science、All Allなどがある。そのUSANA Nutritionals Essentials製品ラインには、約1年の子供から始まるすべての年齢層のための体の栄養の基礎を提供するビタミンおよびミネラルサプリメントが含まれる。Optimizersの製品ラインは、個々の健康と栄養ニーズを満たすように設計された標的補助食品で構成される。Sense-beautiful science製品ラインには、局所栄養、保湿および保護を提供することにより、皮膚および毛髪をサポートする科学ベースのパーソナルケア製品が含まれる。 ユサナ・ヘルスサイエンスは、栄養サプリメントや健康食品を開発・製造する米国メ―カ―。ダイレクトセリングと呼ばれるネットワ―クマ―ケティングシステムを通じ、製品を販売。ビタミンやミネラルのサプリメントなどの主要製品は、「ユサナ」ヘルスパックとエッセンシャル、オプティマイザ―のバイオメガなど。ダイエット食品やパ―ソナルケア用品などもある。 USANA prides itself in providing consumers the highest quality nutritional products in the world. From its award-winning supplements to its innovative skincare line, USANA has proven for more than 25 years why it's a company wworth of trust. |
| 本社所在地 | 3838 West Parkway Blvd. Salt Lake City UT 84120 USA |
| 代表者氏名 | Myron W. Wentz |
| 代表者役職名 | Chairman of the Board |
| 電話番号 | +1 801-954-7100 |
| 設立年月日 | 33786 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 1911人 |
| url | www.usanahealthsciences.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） 205.19600 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 1963.92200 |
| 売上高 | （百万ドル） 1189.24800 |
| 企業価値(EV) | （百万ドル） 1686.05700 |
| 当期純利益 | （百万ドル） 126.22400 |
| 決算概要 | BRIEF: For the fiscal year ended 29 December 2018 USANA Health Sciences Inc. revenues increased 14% to $1.19B. Net income before extraordinary items increased 36% to $126.2M. Revenues reflect East Asia segment increase of 20% to $654.4M South East/Asia Pacific segment increase of 10% to $225.5M. Net income benefited from Interest income increase from $2.2M to $4.4M (income) Research/Development decrease of 1% to $8.8M (expense). |
USNAのテクニカル分析
USNAのニュース
USANA Health Sciences Announces Plans to Expand into India 2023/05/04 12:15:00 Wallstreet:Online
USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets. “USANA’s expansion into India is our first new market in five years and provides an exciting and gratifying opportunity to introduce USANA’s world class health and wellness products to a new country,
USANA Health Sciences, Inc. (NYSE:USNA) Forecasted to Post FY2023 Earnings of $3.05 Per Share 2023/04/29 09:08:41 The AM Reporter
USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) – DA Davidson lifted their FY2023 earnings per share (EPS) estimates for shares of USANA Health Sciences in a note issued to investors on Wednesday, April 26th. DA Davidson analyst L. Weiser now anticipates that the company will post earnings of $3.05 per share for the year, […]
Equities Analysts Issue Forecasts for USANA Health Sciences, Inc.’s Q2 2023 Earnings (NYSE:USNA) 2023/04/28 06:28:51 The AM Reporter
USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) – Analysts at DA Davidson issued their Q2 2023 earnings estimates for USANA Health Sciences in a report issued on Wednesday, April 26th. DA Davidson analyst L. Weiser forecasts that the company will post earnings per share of $0.77 for the quarter. The consensus estimate for USANA […]
USANA Health Sciences, Inc. (USNA) Q1 2023 Earnings Call Transcript 2023/04/26 19:12:20 Seeking Alpha
USANA Health Sciences, Inc. (NYSE:NYSE:USNA) Q1 2023 Earnings Conference Call April 26, 2023 11:00 AM ETCompany ParticipantsAndrew Masuda - Director of Investor RelationsKevin Guest - Chief…
USANA Health Sciences GAAP EPS of $0.95 beats by $0.18, revenue of $248M beats by $7.8M 2023/04/25 20:15:26 Seeking Alpha
USANA Health Sciences press release (USNA): Q1 GAAP EPS of $0.95 beats by $0.18.Revenue of $248M (-9.1% Y/Y) beats by $7.8M.Fiscal 2023 net sales and diluted EPS guidance updated…
USANA Health Sciences Announces Plans to Expand into India 2023/05/04 12:15:00 Wallstreet:Online
USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets. “USANA’s expansion into India is our first new market in five years and provides an exciting and gratifying opportunity to introduce USANA’s world class health and wellness products to a new country,
USANA Health Sciences, Inc. (NYSE:USNA) Forecasted to Post FY2023 Earnings of $3.05 Per Share 2023/04/29 09:08:41 The AM Reporter
USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) – DA Davidson lifted their FY2023 earnings per share (EPS) estimates for shares of USANA Health Sciences in a note issued to investors on Wednesday, April 26th. DA Davidson analyst L. Weiser now anticipates that the company will post earnings of $3.05 per share for the year, […]
Equities Analysts Issue Forecasts for USANA Health Sciences, Inc.’s Q2 2023 Earnings (NYSE:USNA) 2023/04/28 06:28:51 The AM Reporter
USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) – Analysts at DA Davidson issued their Q2 2023 earnings estimates for USANA Health Sciences in a report issued on Wednesday, April 26th. DA Davidson analyst L. Weiser forecasts that the company will post earnings per share of $0.77 for the quarter. The consensus estimate for USANA […]
USANA Health Sciences, Inc. (USNA) Q1 2023 Earnings Call Transcript 2023/04/26 19:12:20 Seeking Alpha
USANA Health Sciences, Inc. (NYSE:NYSE:USNA) Q1 2023 Earnings Conference Call April 26, 2023 11:00 AM ETCompany ParticipantsAndrew Masuda - Director of Investor RelationsKevin Guest - Chief…
USANA Health Sciences GAAP EPS of $0.95 beats by $0.18, revenue of $248M beats by $7.8M 2023/04/25 20:15:26 Seeking Alpha
USANA Health Sciences press release (USNA): Q1 GAAP EPS of $0.95 beats by $0.18.Revenue of $248M (-9.1% Y/Y) beats by $7.8M.Fiscal 2023 net sales and diluted EPS guidance updated…
USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside (NYSE:USNA) 2022/04/28 17:58:41 Seeking Alpha
USANA had a soft quarter due to China’s Covid surge. Read more to find out we see USNA stock as a buying opportunity with 65% upside.
DA Davidson Maintains Neutral Rating for Usana Health Sciences: Here''s What You Need To Know 2022/04/27 20:04:21 Benzinga
DA Davidson has decided to maintain its Neutral rating of Usana Health Sciences (NYSE: USNA ) and lower its price target from $86.00 to $76.00. Shares of Usana Health Sciences are trading up 0.89% over the last 24 hours, at $76.19 per share. A move to $76.00 would account for a 0.25% decrease from the current share price. About Usana Health Sciences Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals'' … Full story available on Benzinga.com
USANA Health Sciences (USNA) Q1 2022 Earnings Call Transcript 2022/04/27 18:00:29 The Motley Fool
USNA earnings call for the period ending March 31, 2022.
USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q1 2022 Results - Earnings Call Transcript 2022/04/27 16:34:10 Seeking Alpha
USANA Health Sciences, Inc. (NYSE:NYSE:USNA) Q1 2022 Results Conference Call April 27, 2022 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest -…